Sarah R. Amend
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Kenneth J. PientaJoel S. BrownK. MyersEmma U. HammarlundKenneth C. ValkenburgRobert H. AustinKatherine N. WeilbaecherRobert Axelrod
- Topics
- Cancer Genomics and Diagnostics (25 papers)Cancer Cells and Metastasis (22 papers)Prostate Cancer Treatment and Research (13 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- United StatesSwedenChina
In The Last Decade
Sarah R. Amend
85 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.3k
- Oncology 708
- Cancer Research 652
- Immunology 543
- Pulmonary and Respiratory Medicine 288
Countries citing papers authored by Sarah R. Amend
This map shows the geographic impact of Sarah R. Amend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah R. Amend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah R. Amend more than expected).
Fields of papers citing papers by Sarah R. Amend
This network shows the impact of papers produced by Sarah R. Amend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah R. Amend. The network helps show where Sarah R. Amend may publish in the future.
Co-authorship network of co-authors of Sarah R. Amend
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah R. Amend. A scholar is included among the top collaborators of Sarah R. Amend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah R. Amend. Sarah R. Amend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 10 | |
| 10 | 3 | |
| 11 | 6 | |
| 12 | 5 | |
| 13 | 8 | |
| 14 | Updating the Definition of Cancerbreakdown → | 263 |
| 15 | 10 | |
| 16 | 16 | |
| 17 | 47 | |
| 18 | 56 | |
| 19 | 40 | |
| 20 | 49 |
About Sarah R. Amend
Sarah R. Amend is a scholar working on Cancer Research, Oncology and Cell Biology, having authored 95 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (25 papers), Cancer Cells and Metastasis (22 papers) and Prostate Cancer Treatment and Research (13 papers). The work is most often cited by research in Cancer Research (652 citations), Oncology (708 citations) and Immunology (543 citations). Sarah R. Amend has collaborated with scholars based in United States, Sweden and China. Frequent co-authors include Kenneth J. Pienta, Joel S. Brown, K. Myers, Emma U. Hammarlund, Kenneth C. Valkenburg, Robert H. Austin, Katherine N. Weilbaecher, Robert Axelrod, Robert A. Gatenby and Jochen G. Schneider. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.